Characteristic | UBC (N = 66) | UTI (N = 40) | Control (N = 48) | p | |||
---|---|---|---|---|---|---|---|
N | % | N | % | N | % | ||
Gender | < 0.001 | ||||||
Male | 59 | 89.4 | 8 | 20.0 | 24 | 50.0 | |
Female | 7 | 10.6 | 32 | 80.0 | 24 | 50.0 | |
Age group | < 0.001 | ||||||
< 48 years | 18 | 27.3 | 28 | 70.0 | 40 | 83.3 | |
≥ 48 year | 48 | 72.7 | 12 | 30.0 | 8 | 16.7 | |
Cigarette-smoking | < 0.001 | ||||||
Yes | 51 | 77.3 | 6 | 15.0 | 20 | 41.7 | |
No | 15 | 22.7 | 34 | 85.0 | 28 | 58.3 | |
Alcohol-consuming | < 0.010 | ||||||
Yes | 20 | 30.3 | 2 | 5.0 | 4 | 8.3 | |
No | 46 | 69.7 | 38 | 95.0 | 44 | 91.7 | |
Family history | |||||||
Yes | 13 | 19.7 | |||||
No | 53 | 80.3 | |||||
Clinical stage | |||||||
I–II | 41 | 62.1 | |||||
III–IV | 25 | 37.9 | |||||
Tumor invasiveness | |||||||
Superficial | 29 | 43.9 | |||||
Invasive | 37 | 56.1 | |||||
Type of therapy | |||||||
Untreated | 19 | 28.8 | |||||
Methotrexate | 33 | 50.0 | |||||
BCG | 14 | 21.2 |